CHEMICAL/BIOLOGICAL DEFENSE (ACD&P)

Abstract

This program element (PE) resources Advanced Component Development and Prototypes across the Enabling Investments, Mitigate, Protect, and Understand portfolios. Program efforts validate high-risk/high-payoff technologies and their respective concepts-of-operations for significant improvement to Warfighter capabilities in preparation for transition of mature technologies to advanced development programs requiring chemical and biological (CB) defense technologies. Chemical Biological Defense Program (CBDP) investments provide an integrated, layered capability to enable Combating Weapons of Mass Destruction (CWMD) missions ranging from combat operations to Department of Defense (DoD) support to domestic incident prevention and response. The Projects in this PE support component and subsystem maturity prior to integration in major, complex systems and may involve risk reduction initiatives and include technology demonstrations. This effort facilitates transitions of Integrated Early Warning and Integrated Layered Defense products. FY23 funding accelerates characterization and situational awareness of emerging biothreats and accelerates delivery of improved protection from and mitigation of biothreats, including rapid repurposing of available therapeutics and development of new vaccines. Individual Projects include: - Enabling Investments (EN4): Development of efforts to evaluate integrated technologies or prototype systems in a high fidelity and realistic operating environment, including system specific efforts that help expedite technology transition from the laboratory to operational use. Increase efforts to improve integration of collective protection into Service major combat platforms. - Mitigate (MT4): Sustain efforts in antiviral therapeutics. Develop capabilities to incorporate the use of in silico, "organs on a chip" and Machine Learning/Artificial Intelligence technologies for drug discovery and development up to phase II trials. Increase efforts regarding platform technologies. Development of repurposing pharmaceuticals that enable a rapid response capability to combat emerging threats. - Protect (PT4): Continued efforts to unencumber the Warfighter by delivering improved personal protection capabilities that incorporate inherent survivability into Service equipment and platforms and which offer protection against the diverse threat agents that near-peer adversaries are developing. Develop capability for next generation individual protective equipment. - Understand (UN4): Maintain effort in distinguishing between bacterial, viral, and toxin diagnostics. Update detector libraries for relevant detection and identification systems. Continue efforts to integrate detection capabilities into Service combat platforms. Develop detection and diagnostic technologies with compatibility to receive and transmit sensor data on Service networks. Identify Service concepts for Integrated Early Warning (IEW) and maintain cyber compliance of fielded Chemical Biological Radiological and Nuclear (CBRN) information systems. - Contamination Avoidance (CA4), Decontamination (DE4), Individual Protection (IP4), Information Systems (IS4), Medical Biological Defense (MB4), Techbase Medical Defense (TM4) and Technology Transition (TT4) are no longer active FY23 Projects due to budget restructure. - Test and Evaluation (TE4) Project concluded in FY21. The projects in this PE support the advanced component technology development phase of the DoD acquisition system and are therefore correctly placed in Budget Activity 4.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2023
Source ID
0603884BP_4_0400_PB_2023
Change Summary Explanation
Funding: FY 2021 (+$5.234 Million): Below threshold reprogramming increase for implementation of common CBRN integrated systems architecture within the CBRN Integrated Early Warning (CBRN IEW) program. FY 2021 (-$2.576 Million): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY 2022 (+$4.500 Million): Congressional Add for development of medical countermeasures against novel entities (DOMANE). FY 2023: Funding increase reflects the fact that the FY 2022 President's Budget request did not include out-year funding. Funding includes specific increases for enhanced biodefense and pandemic preparedness investments (+$150.600 Million), Departmental inflation rate adjustments (+$14.779 Million), for the Compact Vapor Chemical Agent Detector (CVCAD) to continue and complete advanced development on prototype systems and the Plague Monoclonal Antibodies (PLG MAB) program to continue in the discovery of Plague mAbs and manufacturing development (+$7.098 Million). Schedule: N/A Technical: N/A
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Artificial Intelligence
  • Biomedical Research
  • Chemical Detection
  • Chemical Warfare
  • Chemical Warfare Agents
  • Chemical Weapons
  • Command And Control
  • Data Analysis
  • Detection
  • Detectors
  • Infectious Diseases
  • Medical Personnel
  • Personal Protective Equipment
  • Systems Engineering
  • Test And Evaluation
  • Unmanned Aerial Systems
  • Warfare

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Military Science and Technology Research and Modernization.

Technology Areas

  • AI & ML
  • AI & ML - DoD AI Strategy
  • Biotechnology
  • Cyber

Related Documents